Tran B. Nguyen - 15 Mar 2023 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role: Chief Strategy Officer and CFO
Signature: /s/ Michael Malecek, as Attorney in Fact for Tran B. Nguyen
Issuer symbol: PRTA
Transactions as of: 15 Mar 2023
Net transactions value: -$417,014
Form type: 4
Filing time: 17 Mar 2023, 21:31:45 UTC
Previous filing: 03 Mar 2023
Next filing: 17 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRTA	Ordinary Shares, par value $0.01 per share	Options Exercise	$67,300	+10,000	+312%	$6.73^*	13,200	15 Mar 2023	Direct
transaction	PRTA	Ordinary Shares, par value $0.01 per share	Sale	$231,285	-4,802	-36%	$48.16	8,398	15 Mar 2023	Direct	F1, F2
transaction	PRTA	Ordinary Shares, par value $0.01 per share	Sale	$253,029	-5,198	-62%	$48.68	3,200	15 Mar 2023	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRTA	Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-100%	$0.000000^*	0	15 Mar 2023	Ordinary Shares	10,000	$6.73	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and order regarding the separation of assets ("Court Order") in accordance with a divorce settlement agreement.
F2	The transaction was executed in multiple trades in prices ranging from $47.43 to $48.405, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4.
F3	The transaction was executed in multiple trades in prices ranging from $48.43 to $49.03, inclusive.
F4	The option was granted on April 1, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately one month and be forfeited to the extent it is not exercised on or prior to March 31, 2023.
F5	The Reporting Person holds options that give him the right to acquire an aggregate of 901,837 shares at exercise prices ranging from $6.73 to $52.97, of which 721,837 are currently exercisable, and 180,000 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award. Certain of these options are subject to the Court Order.